Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etravirine in HIV-1 Infected Infants and Children
NCT01504841Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Mar 2013
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of etravirine in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Started Mar 2013; status: completed.
02
Drugs
etravirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01504841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01504841.